ORAL CYCLOSPORINE IN PATIENTS WITH SEVERE ACUTE ULCERATIVE COLITIS
- Hepato-Gastroenterology Department, Hassan II University Medical Center, Fez, Morocco, Faculty of Medicine, Sidi Mohammed Ben Abdellah University, Fez Morocco.
Abstract
Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by intermittent exacerbations and remissions. About 15% of patients with UC will have a severe flare of their disease requiring hospitalization. Unfortunately, approximately 30% of patients admitted with severe ulcerative colitis fail intravenous steroids and require surgery or a second-line therapy. Oral cyclosporine has been reported to be useful in inducing remission in patients with corticoresistant severe UC. We present our experience of its use in fourteen patients.
Keywords
Article Analytics
How to Cite This Article
H. Abid, H. Laarabi, M. Lahlali, A. Lamine, N. Lahmidani, M. Elyousfi, D. Benajah, A. Ibrahimi and M. Elabkari (2020); ORAL CYCLOSPORINE IN PATIENTS WITH SEVERE ACUTE ULCERATIVE COLITIS, Int. J. of Adv. Res., 8 (09), 683-686, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/11707
Corresponding Author
This work is licensed under a Creative Commons Attribution 4.0 International License.